Scholars@Duke
Search form
Search
Advanced Search
Support
Index
Subscribe to Announcements
Menu
Search
Home
People
Schools / Institutes
Research
About
Home
People
Schools / Institutes
Research
Semaglutide effects on cardiovascular outcomes in people with overweight or obesity
Administered By
Duke Molecular Physiology Institute
Awarded By
Novo Nordisk, Inc.
Contributors
Abou Assi, Hiba
Principal Investigator
Start/End
March 22, 2019 - March 31, 2023